Cynthia M. Butitta, Chief Operating Officer at Kite Pharma, Inc. (KITE), sold 4,964 shares at $50.86 ($252K) on 2016-12-20, disclosed to the SEC on 2016-12-22.
Open-market sale of $252k KITE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.86 | 2,482 | $126K | 50.0% |
| 2 | $50.86 | 2,482 | $126K | 50.0% |
| Total | $50.86 avg | 4,964 | $252K | 100% |
| Filing → |
| KITE | SELL | 2017-07-11 | $1.5M | — | Filing → |
| KITE | SELL | 2017-06-27 | $711K | — | Filing → |
| KITE | SELL | 2017-06-12 | $885K | — | Filing → |